A revolutionary shift is underway in the realm of agriculture as next-generation...
In the realm of modern chemistry and drug development, the innovative field of b...
Regeneron has adjusted its regulatory approach for odronextamab, opting to pursu...
Teleflex has announced plans to restructure its operations by creating two indep...
Silence Therapeutics recently shared an update regarding its zerlasiran program,...
The Food and Drug Administration (FDA) has canceled its advisory panel meeting o...
New EU Clinical Trial Regulations simplify international trials while offering t...
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers...
The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for trea...
A survey has shown that pharma companies have low confidence their rare disease ...
Medigene and EpimAb Biotherapeutics have signed a co-development agreement invol...
With issues in therapy delivery and a barren trial landscape, short-term chances...
The FDA has accepted Sobi’s sBLA for Gamifant for haemophagocytic lymphohistiocy...
At the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposi...
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials th...
Zevra will use the $150m to support the commercial launches of rare disease drug...
